Management case2.txt Because Titan has a grade III medial congenital patella luxation, which is a condition that will likely deteriorate with time to a higher grade luxation, surgery is the treatment of choice. Traditionally, most grade II and all Grade III and IV patella luxations are managed surgically. Surgery is indicated in dogs in which the frequency of severity of lameness results in a compromise of normal function. In TitanŐs case she is currently experiencing a right hind limb lameness preventing normal ambulation. The surgical goal in this case is to correct the alignment of the quadriceps mechanism and to stabilize the patella within the trochlear groove. There are a number of different ways to approach this problem surgically including: 1. deepening of the trochlear groove 2. tibial tubercle deviation 3. trochleoplasty 4. trochlear sulcoplasty 5. recession sulcoplasty 6. trochlear chondroplasty 7. desmotomy 8. corrective osteotomy (grades III and IV) Again, the ultimate goal is to align and stabilize the patella thus restoring normal function to the right hind limb. In addition to surgery, or in the interim for surgery,the following medications may be dispensed: 1. NSAIDŐs 10-25 mg/kg PO q8h or q12h 2. Caroprofen 2.2 mg/kg PO q 12h 3. Phenylbutazone 3-7 mg/kg PO q8h (<800 mg/day) When using NSAIDŐs potential gi irritation must be considered. Alternative drugs: 1. Chondroprotective drugs such as Polysulfated Glycosaminoglycans, Chondroitan Sulfate, and Glucosamine Contraindicated drugs include: 1. Corticosteroids due to potential side effects and articular cartilage damage. Post surgical care should include the following: 1. Cryotherapy immediately following surgery for 15-20 minutes every 8 hours for a period of 3-5 days. 2. Weight control via diet to decrease the load on the stifle 3. ROM exercises as soon as tolerated and early, active limb use advocated. 4. Exercise limitations for 4 weeks including preventing jumping 5. Monitoring of any onset of acute non-weight bearing lameness as this could indicate CrCL disease. 6. Yearly exam to assess progress